Endovascular stroke therapy: A single-center retrospective review

Jason S. Day, Michael C. Hurley, Mohamad Chmayssani, Rudy J. Rahme, Mark J. Alberts, Richard A. Bernstein, Guilherme Dabus, Ali Shaibani, Bernard R. Bendok

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Object. Endovascular treatment of acute ischemic stroke delivers direct therapy at the site of an occluded cerebral artery and can be employed beyond the 3-4.5-hour window limit set for intravenous recombinant tissue plasminogen activator. In this paper, the authors report their experience with various endovascular therapies in acute ischemic stroke. Methods. The authors conducted a retrospective review of their clinical database for acute ischemic stroke in large-vessel cerebral territories that underwent endovascular treatment between May 2005 and February 2009. Endovascular treatment was defined as pharmacological and/or mechanical intervention, angioplasty, stenting, or a combination of these methods. Admission National Institutes of Health Stroke Scale and the modified Rankin Scale scores were recorded. Thrombolysis in Myocardial Infarction (TIMI) scores of 0, 1, 2A, 2B, and 3 were used to define recanalization. Results. Forty procedures were performed in 39 patients, with 1 patient having sequential bilateral strokes. Nine patients were lost to follow-up after discharge. Strokes in the carotid artery circulation occurred in 82.5% of cases, and those in the vertebral-basilar territory occurred in 17.5%. The Merci device was used in 22 (55%) of 40 procedures, and the Penumbra device in 9 (22.5%) of 40. Angioplasty was performed in 15 (37.5%) of 40 procedures, and intraarterial recombinant tissue plasminogen activator was administered in 23 (57.5%) of 40 procedures. In 23 (57.5%) of 40 cases, multiple recanalization methods were used. The recanalization rate for all methods was 60%. The recanalization rate from TIMI Score 0/1 occlusions was 71.4% (20 of 28). An estimated modified Rankin Scale score of ≤ 2 was obtained in 11 (36.7%) of 30 cases. The overall mortality rate was 26.7% (8 of 30). Intracerebral hemorrhage at 24 hours postprocedure was noted in 17 (42.5%) of 40 cases, 3 (7.5%) of which were symptomatic. Conclusions. The authors' institution performs endovascular stroke treatment with a safety and efficacy profile comparable to those of other major endovascular stroke therapy studies. Recanalization was associated with an improved clinical outcome. Protocols to maximize efficient triage of patients and better documentation of stroke treatments can assist in further studies.

Original languageEnglish (US)
Article numberE10
JournalNeurosurgical focus
Volume30
Issue number6
DOIs
StatePublished - Jun 1 2011

Keywords

  • Endovascular
  • Ischemic
  • Mechanical
  • Pharmacological
  • Stenting
  • Stroke

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Endovascular stroke therapy: A single-center retrospective review'. Together they form a unique fingerprint.

  • Cite this

    Day, J. S., Hurley, M. C., Chmayssani, M., Rahme, R. J., Alberts, M. J., Bernstein, R. A., Dabus, G., Shaibani, A., & Bendok, B. R. (2011). Endovascular stroke therapy: A single-center retrospective review. Neurosurgical focus, 30(6), [E10]. https://doi.org/10.3171/2011.3.FOCUS10267